BioVie, Inc.: BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson's Disease

BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative ...

Safe Harbor Financial Services, Inc.: Safe Harbor Financial Reports First Quarter 2026 Results and Provides Corporate Update

First Quarter 2026 Revenue of Approximately $2.0 Million, Up 2.2% Year Over Year Loan Program Income Up 55.6% Year Over Year to Approximately $0.8 Million Total Operating Expenses Down 4.7% Year Over ...

XVIVO Perfusion AB: Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology

GOTHENBURG, SE / ACCESS Newswire / May 18, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Hôpital La Pitié-Salpêtrière (Sorbonne University) in Paris, France, has, since the approval of a ...

Inspira Technologies: NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that it has received a $580,000 commercial purchase ...
Finanznachrichten

NextEra Energy, Inc. and Dominion Energy, Inc. to Combine, Creating the World's Largest Regulated Electric Utility Business and North America's Premier Energy Infrastructure ...

Creates the world's largest regulated electric utility business by market capitalization and one of the world's largest energy infrastructure companies with an unmatched operating platform benefiting ...

Daré Bioscience, Inc.: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

Each year, an estimated six million women in the United States acquire a high-risk HPV infection - and there are no FDA-approved treatments DARE-HPV development is backed by a $10 million U.S. governm ...

Anterix Inc.: Anterix and Lynk Global Receive FCC Approval to Test 900 MHz Satellite-Enabled Direct-to-Device Enterprise Communications

Anterix (NASDAQ: ATEX), the market leader in enabling mission-critical private wireless broadband networks, and satellite telecommunications provider ...

Core AI Holdings, Inc.: Core AI Holdings Reports Record 59% Revenue Growth and Strategic AI Expansion

Core AI Holdings, Inc. (Nasdaq: CHAI) ("Core AI" or the "Company"), a global AI infrastructure and technology platform today announced financial results for ...

National Healthcare Properties Announces Tender Offers

National Healthcare Properties, Inc. (Nasdaq: NHP / NHPAP / NHPBP) (the "Company"), a self-managed real estate investment trust focused on acquiring, owning ...

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation ...

YY Group Holding Limited: YY Group (NASDAQ: YYGH) Expands Malaysia Operations to Melaka, Entering New High-Growth Hospitality Market

Partnership with international 5-star hotel broadens the Company's recurring revenue base and enhances regional visibility SINGAPORE, May 18, 2026 /PRNewswire/ -- ...

Kyverna Therapeutics, Inc.: Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune ...